Eric Venker - Oct 20, 2024 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
President & COO
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker
Stock symbol
ROIV
Transactions as of
Oct 20, 2024
Transactions value $
-$910,464
Form type
4
Date filed
10/22/2024, 09:00 PM
Previous filing
Sep 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Tax liability -$130K -10.9K -1.74% $11.92 617K Oct 20, 2024 Direct F1
transaction ROIV Common Shares Options Exercise $385K +100K +16.2% $3.85 717K Oct 21, 2024 Direct
transaction ROIV Common Shares Sale -$1.17M -100K -13.94% $11.65 617K Oct 21, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ROIV Stock Option (Right to Buy) Options Exercise $0 -100K -0.8% $0.00 12.4M Oct 21, 2024 Common Stock 100K $3.85 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.
F2 The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
F3 Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation).